000 | 01772 a2200517 4500 | ||
---|---|---|---|
005 | 20250514011955.0 | ||
264 | 0 | _c20020214 | |
008 | 200202s 0 0 eng d | ||
022 | _a1076-1551 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEidelman, O | |
245 | 0 | 0 |
_aControl of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. _h[electronic resource] |
260 |
_bMolecular medicine (Cambridge, Mass.) _cAug 2001 |
||
300 |
_a523-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCluster Analysis |
650 | 0 | 4 |
_aCystic Fibrosis _xgenetics |
650 | 0 | 4 |
_aCystic Fibrosis Transmembrane Conductance Regulator _xgenetics |
650 | 0 | 4 |
_aEpithelial Cells _xmetabolism |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-8 _xmetabolism |
650 | 0 | 4 |
_aLung _xmetabolism |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNF-kappa B _xgenetics |
650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xphysiology |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xgenetics |
650 | 0 | 4 |
_aRespiratory Mucosa _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aXanthines _xtherapeutic use |
700 | 1 | _aSrivastava, M | |
700 | 1 | _aZhang, J | |
700 | 1 | _aLeighton, X | |
700 | 1 | _aMurtie, J | |
700 | 1 | _aJozwik, C | |
700 | 1 | _aJacobson, K | |
700 | 1 | _aWeinstein, D L | |
700 | 1 | _aMetcalf, E L | |
700 | 1 | _aPollard, H B | |
773 | 0 |
_tMolecular medicine (Cambridge, Mass.) _gvol. 7 _gno. 8 _gp. 523-34 |
|
999 |
_c11512042 _d11512042 |